Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4746957
Max Phase: Preclinical
Molecular Formula: C29H28ClNO2
Molecular Weight: 458.00
Molecule Type: Unknown
Associated Items:
ID: ALA4746957
Max Phase: Preclinical
Molecular Formula: C29H28ClNO2
Molecular Weight: 458.00
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1(C)C=Cc2c(c(C=O)cc3c4cc(C(C)(C)C)ccc4n(Cc4cccc(Cl)c4)c23)O1
Standard InChI: InChI=1S/C29H28ClNO2/c1-28(2,3)20-9-10-25-23(15-20)24-14-19(17-32)27-22(11-12-29(4,5)33-27)26(24)31(25)16-18-7-6-8-21(30)13-18/h6-15,17H,16H2,1-5H3
Standard InChI Key: VWVCTMYWIZLDBL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 458.00 | Molecular Weight (Monoisotopic): 457.1809 | AlogP: 7.79 | #Rotatable Bonds: 3 |
Polar Surface Area: 31.23 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.80 | CX LogD: 7.80 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.29 | Np Likeness Score: 0.25 |
1. Liu K,Zang Y,Shen C,Li C,Ma J,Yang J,Sun X,Chen X,Wang N,Zhang D. (2021) Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents., 33 [PMID:33316408] [10.1016/j.bmcl.2020.127739] |
Source(1):